Steph & Co’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$480K Buy
3,799
+514
+16% +$67.7K 0.12% 65
2026
Q1
$458K Buy
3,285
+31
+1% +$4.34K 0.13% 61
2025
Q4
$399K Sell
3,254
-642
-16% -$78K 0.12% 65
2025
Q3
$432K Sell
3,896
-2,633
-40% -$299K 0.13% 66
2025
Q2
$724K Sell
6,529
-371
-5% -$39.5K 0.23% 42
2025
Q1
$773K Sell
6,900
-531
-7% -$54.8K 0.28% 35
2024
Q4
$686K Sell
7,431
-212
-3% -$19.1K 0.23% 45
2024
Q3
$641K Buy
7,643
+129
+2% +$9.84K 0.2% 48
2024
Q2
$516K Buy
7,514
+143
+2% +$9.54K 0.18% 53
2024
Q1
$540K Sell
7,371
-177
-2% -$13.6K 0.19% 56
2023
Q4
$611K Buy
7,548
+142
+2% +$11.1K 0.3% 41
2023
Q3
$555K Buy
7,406
+225
+3% +$17.3K 0.31% 44
2023
Q2
$553K Buy
7,181
+36
+0.5% +$2.87K 0.3% 45
2023
Q1
$593K Sell
7,145
-498
-7% -$41.2K 0.37% 42
2022
Q4
$656K Buy
7,643
+401
+6% +$31.8K 0.41% 41
2022
Q3
$447K Buy
+7,242
New +$457K 0.31% 47

Other funds holding GILD

Steph & Co's GILD Position: Q2 2026 in Review

Steph & Co increased its Gilead Sciences (GILD) stake by 16% in Q2 2026, buying an estimated $67.7K and bringing the position to 3,799 shares worth $480K. The position accounts for 0.12% of the portfolio, ranked #65.

Steph & Co first reported a position in GILD in Q3 2022 and has held it in 16 quarters since. The position peaked at $773K in Q1 2025. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Steph & Co held 3,799 shares of Gilead Sciences worth $480K as of Q2 2026.
  • Steph & Co bought 514 Gilead Sciences shares in Q2 2026, an estimated $67.7K.
  • Gilead Sciences made up 0.12% of Steph & Co's portfolio in Q2 2026, its #65 holding.
  • Steph & Co first reported a position in Gilead Sciences in Q3 2022 and has held it in 16 quarters since.
  • Steph & Co's Gilead Sciences position peaked at $773K in Q1 2025.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.